Zimmer Biomet Holdings, Inc. provided earnings guidance for the full year 2024. The company expects 2024 reported revenue change to be 4.5% - 5.5%.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
120.8 USD | -0.48% | +1.08% | -0.70% |
May. 03 | Raymond James Adjusts Price Target on Zimmer Biomet Holdings to $138 From $142 | MT |
May. 03 | UBS Adjusts Price Target on Zimmer Biomet Holdings to $112 From $109, Maintains Sell Rating | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-0.70% | 24.86B | |
-4.66% | 183B | |
-1.01% | 108B | |
-4.20% | 67.51B | |
+2.68% | 50.67B | |
+9.12% | 44.7B | |
+2.41% | 40.95B | |
+4.13% | 26.71B | |
+3.31% | 26.8B | |
+12.66% | 24.62B |
- Stock Market
- Equities
- ZBH Stock
- News Zimmer Biomet Holdings, Inc.
- Zimmer Biomet Holdings, Inc. Provides Earnings Guidance for the Full Year 2024